Sign in or register to see full information and data.

Studies / CAVD 278

Overview

Study information

Network:CAVD
Grant Affiliation:Lewis: Ab Specificity & Fc-Mediated Protection
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2012-01-12
Study Made Public:2012-10-10

Title

Specificity of anti-gp41 monoclonal antibodies that mediate ADCC

Description

CAVD 278 (CAVIMC-040) is an immunogenicity study to define the epitopes recognized by a panel of anti-gp41 monoclonal antibodies that mediate ADCC.

Products

No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.